Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: |
Title | Visgenx |
Description | Bringing Retinal Health into Home Science Therapeutic Strategy Team Contact Contact Bringing Retinal Health into focus Therapeutics for Dry Age-Related Macular Degeneration Our Scienc |
Keywords | N/A |
WebSite | visgenx.com |
Host IP | 198.71.232.3 |
Location | United States |
Site | Rank |
US$1,992,509
Last updated: 2023-05-03 06:52:00
visgenx.com has Semrush global rank of 5,312,050. visgenx.com has an estimated worth of US$ 1,992,509, based on its estimated Ads revenue. visgenx.com receives approximately 229,905 unique visitors each day. Its web server is located in United States, with IP address 198.71.232.3. According to SiteAdvisor, visgenx.com is safe to visit. |
Purchase/Sale Value | US$1,992,509 |
Daily Ads Revenue | US$1,840 |
Monthly Ads Revenue | US$55,178 |
Yearly Ads Revenue | US$662,126 |
Daily Unique Visitors | 15,327 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
visgenx.com. | A | 599 | IP: 198.71.232.3 |
visgenx.com. | NS | 3600 | NS Record: ns45.domaincontrol.com. |
visgenx.com. | NS | 3600 | NS Record: ns46.domaincontrol.com. |
visgenx.com. | MX | 3600 | MX Record: 10 mx1-us1.ppe-hosted.com. |
visgenx.com. | MX | 3600 | MX Record: 20 mx2-us1.ppe-hosted.com. |
visgenx.com. | TXT | 3600 | TXT Record: MS=ms41886726 |
visgenx.com. | TXT | 3600 | TXT Record: v=spf1 a:dispatch-us.ppe-hosted.com include:spf.protection.outlook.com -all |
Home Science Therapeutic Strategy Team Contact Contact Bringing Retinal Health into focus Therapeutics for Dry Age-Related Macular Degeneration Our Science » Mission Therapeutics for Macular Degeneration and Other Age-Related Disorders » Visgenx is developing therapeutics based on increasing expression of a gene known as ELOVL2 which has been shown to regulate aging in the retina and other tissues. Our lead indication is Dry Age-Related Macular Degeneration (Dry AMD). Our Therapuetic Strategy » Dry-AMD Overview Dry-AMD is a progressive disease Resulting in loss of photoreceptor cells and visual acuity Patients struggle with everyday tasks Such as driving, cooking, reading, and facial recognition 11 million people are affected in the US There are no approved therapies Young Retina Aging Retina ELOVL2 DHA & VLC PUFAS ELOVL2 DHA & VLC PUFAS Technology Age-Related Macular Degeneration and Geographic Atrophy » We believe dysregulation of lipid (fatty acid) bio-synthesis resulting from |
HTTP/1.1 301 Moved Permanently location: https://visgenx.com/ Vary: Accept-Encoding Server: DPS/1.11.8 X-SiteId: 2000 Set-Cookie: dps_site_id=2000; path=/ Date: Mon, 25 Oct 2021 14:04:16 GMT Connection: keep-alive Keep-Alive: timeout=5 HTTP/2 404 content-type: text/html;charset=utf-8 content-length: 964 vary: Accept-Encoding server: DPS/1.11.8 x-siteid: 2000 set-cookie: dps_site_id=2000; path=/; secure date: Mon, 25 Oct 2021 14:04:17 GMT |
Domain Name: VISGENX.COM Registry Domain ID: 2317107666_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-10-03T14:46:34Z Creation Date: 2018-10-03T00:55:45Z Registry Expiry Date: 2021-10-03T00:55:45Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS45.DOMAINCONTROL.COM Name Server: NS46.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T17:16:58Z <<< |